Cargando…
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Clinically, it is characterized by a progressive degeneration of dopaminergic neurons (DAn), resulting in severe motor complications. Preclinical and clinical studies have indicated that neuroinflammation can...
Autores principales: | Araújo, Bruna, Caridade-Silva, Rita, Soares-Guedes, Carla, Martins-Macedo, Joana, Gomes, Eduardo D., Monteiro, Susana, Teixeira, Fábio G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497016/ https://www.ncbi.nlm.nih.gov/pubmed/36139483 http://dx.doi.org/10.3390/cells11182908 |
Ejemplares similares
-
N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson’s Disease Rat Model
por: Caridade-Silva, Rita, et al.
Publicado: (2023) -
Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration
por: Bartels, Anna L, et al.
Publicado: (2010) -
Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018) -
Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration
por: Batista, Carla Ribeiro Alvares, et al.
Publicado: (2019) -
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
por: Arena, G., et al.
Publicado: (2022)